Literature DB >> 14567630

Assessment of temporal biochemical and gene transcription changes in rat liver cytochrome P450: utility of real-time quantitative RT-PCR.

Federico M Goodsaid1, Jairam R Palamanda, Diana Montgomery, George Mandakas, Chunyan Gu, Zhiling Li, Xiaoli You, Laura Norton, Roger Smith, Inhou Chu, Tony Soares, Kevin Alton, Narendra S Kishnani, I Y Rosenblum.   

Abstract

PURPOSE: A conventional approach to assess cytochrome P450 (CYP) induction in preclinical animal models involves daily dosing for a least a week followed by Western blot and/or enzyme activity analysis. To evaluate the potential benefit of a third more specific and sensitive assay, real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR), with the objective of reducing the duration of the conventional 1-week study, we simultaneously assessed gene expression by qRT-PCR along with Western blots and enzyme activity assays as a time course in an in vivo model.
METHODS: Rats were dosed daily for 8 days with model inducers of CYP1A, CYP2B, CYP3A, or CYP4A. Liver P450 levels were measured after 0.5, 1, 2, 4, and 8 days of dosing by qRT-PCR, Western blot, and enzyme activity.
RESULTS: CYP1A, CYP3A, and CYP4A genes were maximally induced very rapidly (0.5-1 day), whereas the CYP2B gene was maximally induced after a lag time of 4 days. In all cases, fold changes in induction detected by qRT-PCR were greater than fold changes in protein levels and enzyme activities.
CONCLUSIONS: Maximal persistent and larger fold changes observed by qRT-PCR either preceded or occurred simultaneously with maximal sustained fold changes in protein levels as measured by Western blots and enzyme activity assays. Our data show that qRT-PCR provides increased sensitivity and specificity over conventional assays and may be key information for reliable assessment of drug-related changes in CYP induction during the transition from discovery to toxicology studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567630     DOI: 10.1023/a:1025793707794

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

Review 1.  Implications and consequences of enzyme induction on preclinical and clinical drug development.

Authors:  P D Worboys; D J Carlile
Journal:  Xenobiotica       Date:  2001 Aug-Sep       Impact factor: 1.908

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis.

Authors:  C Ioannides; D V Parke
Journal:  Drug Metab Rev       Date:  1993       Impact factor: 4.518

5.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

6.  Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR.

Authors:  Jun Zhang; Wendong Huang; Steven S Chua; Ping Wei; David D Moore
Journal:  Science       Date:  2002-10-11       Impact factor: 47.728

7.  Cytochrome P450 induction in rat hepatocytes assessed by quantitative real-time reverse-transcription polymerase chain reaction and the RNA invasive cleavage assay.

Authors:  M E Burczynski; M McMillian; J B Parker; S Bryant; A Leone; E R Grant; J M Thorne; Z Zhong; R A Zivin; M D Johnson
Journal:  Drug Metab Dispos       Date:  2001-09       Impact factor: 3.922

8.  Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line.

Authors:  J Hukkanen; A Lassila; K Päivärinta; S Valanne; S Sarpo; J Hakkola; O Pelkonen; H Raunio
Journal:  Am J Respir Cell Mol Biol       Date:  2000-03       Impact factor: 6.914

9.  Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.

Authors:  M D Burke; S Thompson; R J Weaver; C R Wolf; R T Mayer
Journal:  Biochem Pharmacol       Date:  1994-08-30       Impact factor: 5.858

10.  In vitro induction of cytochrome P450 2B1- and 3A1-mRNA and enzyme immunostaining in cryopreserved precision-cut rat liver slices.

Authors:  R Glöckner; P Steinmetzer; A Lupp; M Danz; D Müller
Journal:  Toxicology       Date:  2002-07-15       Impact factor: 4.221

View more
  1 in total

1.  Alleviation of ischemia/reperfusion injury in ob/ob mice by inhibiting UCP-2 expression in fatty liver.

Authors:  Chi-Dan Wan; Chun-You Wang; Tao Liu; Rui Cheng; Hong-Bo Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.